Compounds > n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
Page last updated: 2024-08-24

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Adrenal Cancer

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chezmar, JL; Matteucci, T; Mitchell, DG; Outwater, EK; Rubin, DL; Saini, S1

Trials

1 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Adrenal Cancer

ArticleYear
Adrenal gland enhancement at MR imaging with Mn-DPDP.
    Radiology, 1995, Volume: 194, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate

1995